PD-200,347
PD-200,347 is a synthetic compound that acts as a selective antagonist of the α1-adrenergic receptor subtypes. It is primarily used in research settings to study the physiological and pharmacological roles of these receptors in various tissues.
Chemical Structure and Properties[edit | edit source]
PD-200,347 is a chemical compound with the molecular formula C19H21N3O2. It belongs to the class of organic compounds known as phenethylamines, which are characterized by a phenethylamine backbone. The compound is specifically designed to interact with adrenergic receptors, which are a class of G protein-coupled receptors (GPCRs) that are targets for catecholamines like norepinephrine and epinephrine.
Mechanism of Action[edit | edit source]
PD-200,347 functions as an antagonist at the α1-adrenergic receptor subtypes, which include α1A, α1B, and α1D. By binding to these receptors, PD-200,347 inhibits the action of endogenous catecholamines, thereby blocking the physiological responses typically mediated by these receptors. This makes it a valuable tool for dissecting the roles of α1-adrenergic receptors in various biological processes.
Research Applications[edit | edit source]
PD-200,347 is used extensively in pharmacological research to:
- Investigate the role of α1-adrenergic receptors in cardiovascular function, including their involvement in regulating blood pressure and vascular tone.
- Study the effects of α1-adrenergic receptor blockade in the central nervous system, particularly in relation to stress and anxiety responses.
- Explore the potential therapeutic applications of α1-adrenergic receptor antagonists in conditions such as benign prostatic hyperplasia and hypertension.
Pharmacokinetics[edit | edit source]
The pharmacokinetic profile of PD-200,347, including its absorption, distribution, metabolism, and excretion, is primarily characterized in preclinical studies. These studies help determine the compound's bioavailability and duration of action, which are critical for its use in experimental settings.
Safety and Toxicology[edit | edit source]
As with many research chemicals, the safety and toxicological profile of PD-200,347 is not fully established in humans. It is primarily used in controlled laboratory environments, and researchers must adhere to safety guidelines to minimize potential risks.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD